Results 81 to 90 of about 9,762 (221)
Smoking-related interstitial lung disease [PDF]
Cigarette smoking has a clear epidemiological association with lung diseases, characterised by chronic inflammation of both the bronchiolar and the interstitial lung compartments.
CERRI, Stefania +3 more
core +1 more source
A 42‐year‐old man with persistent ESR elevation and peri‐ocular xanthomas was diagnosed with Erdheim–Chester disease via biopsy of the accessible cutaneous lesion, supported by characteristic “hairy kidney” imaging and symmetric skeletal uptake.
Mohammad Rahimi +4 more
wiley +1 more source
Background Juvenile xanthogranuloma (JXG) belongs to the heterogeneous group of non-Langerhans cell histiocytosis and is caused by an accumulation and proliferation of macrophages.
Michaela Höck +6 more
doaj +1 more source
An 11‐Month‐Old Infant With Unusual Diaper Dermatitis
JEADV Clinical Practice, EarlyView.
Majda Chaoui +2 more
wiley +1 more source
Isolated gastrointestinal Langerhans cell histiocytosis in a 16‐month‐old child: A case report
Abstract Langerhans cell histiocytosis (LCH) is a rare disorder characterized by clonal proliferation of Langerhans cells, most often involving the skin or bone. Isolated gastrointestinal (GI) involvement is extremely uncommon in young children. We report a 16‐month‐old girl with a 1‐month history of chronic vomiting, bloody diarrhea, and failure to ...
Al‐Qasim AL‐Bahlani +3 more
wiley +1 more source
Airway involvement in interstitial lung disease [PDF]
PURPOSE OF REVIEW: After briefly discussing several ways to approach airway involvement in interstitial lung diseases - by diagnostic methodologies used to assess it, considering different topographical involvement, related to its presence in the diffuse
Robalo-Cordeiro, C
core +1 more source
MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis
Background: Activation of the MAPK pathway through BRAF mutations or other molecular alterations is a hallmark of the non-Lagerhans cell histiocytosis (non-LCH) such Erdheim-Chester disease (ECD) or Rosai-Dorfman disease (RDD). Conventional clinical molecular testing of tumor tissue fails to identify targetable molecular alteration in about one third ...
Filip Janku +5 more
openaire +1 more source
A 50‐year‐old man with a 12‐year history of extensive pachymeningeal thickening
Brain Pathology, EarlyView.
Alyssa M. Lee +3 more
wiley +1 more source
WHO classification of skin tumours: key updates in the fifth edition
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Gabrielle Goldman‐Lévy +29 more
wiley +1 more source
Erdheim-Chester disease (ECD) is a rare, non-Langerhans cell histiocytosis presenting most commonly with bone and central nervous system symptoms, including but not limited to bone pain and diabetes insipidus.
Farid Arman +4 more
doaj +1 more source

